New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

IXJvsJDOCETF Comparison

ETF 1
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
-1.73%
VS
ETF 2
JDOC

JPMorgan Healthcare Leaders ETF

This fund is part of
Global Blended Cap
-1.38%

iShares Global Healthcare ETF (IXJ) belongs to the Global Large Cap segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. IXJ's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. In contrast, JDOC's top sector exposures are Healthcare and Consumer Non-Cyclicals. IXJ is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.65% for JDOC. IXJ is up 16.67% year-to-date (YTD) with -$490M in YTD flows. JDOC performs worse with 13.4% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of IXJ and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IXJ vs JDOC performance and flow charts

Performance

-20246810%Sep 30Oct 7Oct 14Oct 21Oct 28

Cumulative Flows

-100,000,000-80,000,000-60,000,000-40,000,000-20,000,0000Sep 30Oct 7Oct 14Oct 21Oct 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/30/2026
1M3MYTD1Y3Y5Y
Perf.
IXJ
JDOC
+10.14%+8.75%
+11.22%+7.11%
+16.67%+13.40%
+25.25%+20.53%
+49.00%+37.08%
+37.74%n/a
Flows
IXJ
JDOC
-$103M-
+$40M-
-$490M-$34K
-$351M-$34K
-$619M+$7M
+$13M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
IXJ
JDOC
+16.93%+16.02%
+15.94%+15.63%
+14.42%+14.85%
+14.66%n/a
Max drawdown
IXJ
JDOC
-6.30%-7.92%
-10.83%-9.66%
-18.04%-24.04%
-18.04%n/a
Max drawdown duration
IXJ
JDOC
55d64d
122d154d
490d704d
490dn/a
Trading data

Create an account to view trading data

Join for free
IXJ
JDOC
Last sale
10/30/2026 at 1:30 PM
$112.66
$65.67
Previous close
10/29/2026
$111.74
$65.34
Consolidated volume
10/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

JDOC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
IXJ
JDOC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
IXJ
JDOC
Last price
$112.66
$65.67
1D performance
+0.82%
+0.49%
AuM$4.65 B$9.84 M
E/R0.38%0.65%
Characteristics
IXJ
JDOC
Management strategyPassiveActive
ProvideriSharesJ.P. Morgan Asset Management
BenchmarkS&P Global 1200 Health Care (Sector) Capped Index-
N° of holdings10957
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 13, 2001November 1, 2023
ESGNoNo
Advertisement
Exposure

Countries

IXJ
USA
71.85%
Switzerland
9.64%
Other
18.51%
JDOC
USA
73.09%
Other
26.91%

Sectors

IXJ
Healthcare
97.24%
Other
2.76%
JDOC
Healthcare
96.41%
Other
3.59%

Diversification

IXJ

Total weight of top 15 holdings out of 15

57.19%
JDOC

Total weight of top 15 holdings out of 15

60.13%

Top 15 holdings

Data as of September 30, 2026
IXJ
Eli Lilly & Co.
10.43%
Johnson & Johnson
7.19%
AbbVie, Inc.
5.21%
Merck & Co., Inc.
4.43%
UnitedHealth Group, Inc.
4.07%
Roche Holding AG
3.64%
Novartis AG
3.26%
AstraZeneca PLC
3.13%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
2.82%
Gilead Sciences, Inc.
2.29%
Abbott Laboratories
2.12%
Pfizer Inc.
2.01%
Intuitive Surgical, Inc.
1.78%
Danaher Corp.
1.72%
JDOC
AbbVie, Inc.
8.30%
Eli Lilly & Co.
7.97%
Merck & Co., Inc.
5.08%
Johnson & Johnson
4.98%
Thermo Fisher Scientific, Inc.
4.61%
AstraZeneca PLC
4.10%
UnitedHealth Group, Inc.
3.60%
Bristol Myers Squibb Co.
3.18%
Abbott Laboratories
2.97%
Roche Holding AG
2.81%
Danaher Corp.
2.76%
argenx SE
2.65%
Novo Nordisk A/S
2.57%
IQVIA Holdings, Inc.
2.31%
CVS Health Corp.
2.23%
Frequently asked questions about IXJ and JDOC

How have the IXJ and JDOC ETFs performed in 2026?

As of October 30, 2026, IXJ is up 16.67% year-to-date (YTD), while JDOC has returned 13.4%. That puts IXJ better performer ahead so far this year.

Which ETF is attracting more investor money: IXJ or JDOC?

Year-to-date, the IXJ ETF saw -$490M in flows, compared to -$34K for JDOC.

Which ETF is more volatile: IXJ or JDOC?

Over the past year, IXJ had a volatility of 15.94%, while JDOC experienced 15.63%.

Which ETF is bigger: IXJ or JDOC?

As of October 30, 2026, IXJ holds $4.65 B in assets under management (AUM), while JDOC manages $9.84 M.

What sectors do the IXJ and JDOC ETFs invest in?

IXJ leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.

What are the top holdings of the IXJ ETF and JDOC ETF?

IXJ top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. JDOC holds in its top three: AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc..

Which ETF is more diversified: IXJ or JDOC?

IXJ holds 110 securities with 57.19% of its assets in the top 15. JDOC has 58 securities and a top 15 weight of 60.13%.

Advertisement
Latest news about IXJ & JDOC
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026